{"id":"W4386465472","doi":"10.1093/jcag/gwad015","title":"The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape","year":2023,"lang":"en","type":"review","venue":"Journal of the Canadian Association of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; McMaster University; University of Saskatchewan; Memorial University of Newfoundland; Crohn's and Colitis Canada; McGill University; University of Ottawa; Institute for Clinical Evaluative Sciences; McGill University Health Centre; Public Health Ontario; Mount Sinai Hospital; University of Calgary; Dalhousie University; University of Toronto; SickKids Foundation; University of Manitoba; Ottawa Hospital","funders":"Canadian Institutes of Health Research; Takeda Canada; Pfizer Canada; Janssen Canada; Amgen Canada; Bristol-Myers Squibb Canada; Goddard Space Flight Center; Sandoz Canada; Eli Lilly Canada; Crohn's and Colitis Canada; Pfizer; Hospital for Sick Children; Mylan; Canadian Association of Gastroenterology; Gilead Sciences; Dairy Farmers of Ontario; Takeda Foundation; Merck Canada; University of Toronto; AbbVie Canada; Amgen; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Biosimilar; Inflammatory bowel disease; Disease; Intensive care medicine; Infliximab; Targeted therapy; Inflammatory Bowel Diseases; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001252735,0.001038441,0.001237374,0.003457509,0.001100164,0.002164363,0.001260844,0.001971215,0.008482841],"category_scores_gemma":[0.002211137,0.0002537223,0.0006747855,0.005029669,0.0008849291,0.001037093,0.0008518829,0.00233327,0.002023033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02004351,"about_ca_system_score_gemma":0.04937619,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5730271,"about_ca_topic_score_gemma":0.7350075,"domain_scores_codex":[0.999418,0.00005387579,0.00004187888,0.00004285725,0.0003351225,0.0001082402],"domain_scores_gemma":[0.9981279,0.0001915458,0.0001180302,0.00001599509,0.001227726,0.0003188117],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001109831,0.00003692854,0.0004850905,0.01367119,0.00009873141,0.0001675895,0.00009927677,0.0003606651,0.0004236796,0.005097043,0.2550081,0.7244408],"study_design_scores_gemma":[0.0000225021,0.0000364984,0.002616139,0.008535157,0.000119495,0.000354665,0.0001218389,0.00009934152,0.000114279,0.0009184194,0.9870373,0.00002443205],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007438878,0.9948105,0.00002653008,0.002704642,0.0005115292,0.000004398967,0.00008231708,0.000009598913,0.001776178],"genre_scores_gemma":[0.0009990651,0.9961094,0.0001099489,0.001091712,0.0002535625,0.000004194284,0.0001026066,0.000002823713,0.00132672],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4269729,"threshold_uncertainty_score":0.8589748,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00978450695751201,"score_gpt":0.2523615043781683,"score_spread":0.2425769974206563,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}